Treatment of Bronchospastic Disorders in the 1990s. What Does the Future Hold?

Overview

Journal Drugs

Specialty Pharmacology

Date 1993 Jul 1

PMID 7691502

Authors

P G Gianaris

J A Golish

Affiliations

Soon will be listed here.

References

Mullarkey M, Blumenstein B, Andrade W, Bailey G, Olason I, Wetzel C . Methotrexate in the treatment of corticosteroid-dependent asthma. A double-blind crossover study. N Engl J Med. 1988; 318(10):603-7. DOI: 10.1056/NEJM198803103181004. View

Rafferty P, Ng W, Phillips G, Clough J, Church M, Aurich R . The inhibitory actions of azelastine hydrochloride on the early and late bronchoconstrictor responses to inhaled allergen in atopic asthma. J Allergy Clin Immunol. 1989; 84(5 Pt 1):649-57. DOI: 10.1016/0091-6749(89)90292-3. View

Manning P, Watson R, Margolskee D, Williams V, SCHWARTZ J, OByrne P . Inhibition of exercise-induced bronchoconstriction by MK-571, a potent leukotriene D4-receptor antagonist. N Engl J Med. 1990; 323(25):1736-9. DOI: 10.1056/NEJM199012203232504. View

Knapp H . Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. N Engl J Med. 1990; 323(25):1745-8. DOI: 10.1056/NEJM199012203232506. View

Evans T, Chung K, Rogers D, Barnes P . Effect of platelet-activating factor on airway vascular permeability: possible mechanisms. J Appl Physiol (1985). 1987; 63(2):479-84. DOI: 10.1152/jappl.1987.63.2.479. View

Berti F, Rossoni G, Buschi A, Robuschi M, Villa L . Antianaphylactic and antihistaminic activity of the non-steroidal anti-inflammatory compound nimesulide in guinea-pig. Arzneimittelforschung. 1990; 40(9):1011-6. View

Israel E, Dermarkarian R, Rosenberg M, Sperling R, Taylor G, Rubin P . The effects of a 5-lipoxygenase inhibitor on asthma induced by cold, dry air. N Engl J Med. 1990; 323(25):1740-4. DOI: 10.1056/NEJM199012203232505. View

Schudt C, Winder S, Muller B, Ukena D . Zardaverine as a selective inhibitor of phosphodiesterase isozymes. Biochem Pharmacol. 1991; 42(1):153-62. DOI: 10.1016/0006-2952(91)90694-z. View

Patel K, Peers E . Felodipine, a new calcium antagonist, modifies exercise-induced asthma. Am Rev Respir Dis. 1988; 138(1):54-6. DOI: 10.1164/ajrccm/138.1.54. View

10.

Chung K, Barnes P . PAF antagonists. Their potential therapeutic role in asthma. Drugs. 1988; 35(2):93-103. DOI: 10.2165/00003495-198835020-00001. View

11.

Koltai M, Hosford D, Guinot P, Esanu A, Braquet P . PAF. A review of its effects, antagonists and possible future clinical implications (Part II). Drugs. 1991; 42(2):174-204. DOI: 10.2165/00003495-199142020-00002. View

12.

SCHILD H, Hawkins D, MONGAR J, HERXHEIMER H . Reactions of isolated human asthmatic lung and bronchial tissue to a specific antigen; histamine release and muscular contraction. Lancet. 1951; 2(6679):376-82. DOI: 10.1016/s0140-6736(51)91554-1. View

13.

Weber K . Triazolodiazepines: dissociation of their Paf (platelet activating factor) antagonistic and CNS activity. Br J Pharmacol. 1987; 90(1):139-46. PMC: 1917269. DOI: 10.1111/j.1476-5381.1987.tb16833.x. View

14.

Katayama S, Tsunoda H, Sakuma Y, Kai H, Tanaka I, Katayama K . Effect of azelastine on the release and action of leukotriene C4 and D4. Int Arch Allergy Appl Immunol. 1987; 83(3):284-9. DOI: 10.1159/000234309. View

15.

Toogood J . High-dose inhaled steroid therapy for asthma. J Allergy Clin Immunol. 1989; 83(2 Pt 2):528-36. DOI: 10.1016/0091-6749(89)90034-1. View

16.

Koltai M, Hosford D, Guinot P, Esanu A, Braquet P . Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I). Drugs. 1991; 42(1):9-29. DOI: 10.2165/00003495-199142010-00002. View

17.

Sears M, Taylor D, Print C, Lake D, Li Q, Flannery E . Regular inhaled beta-agonist treatment in bronchial asthma. Lancet. 1990; 336(8728):1391-6. DOI: 10.1016/0140-6736(90)93098-a. View

18.

Ollerenshaw S, Jarvis D, Woolcock A, Sullivan C, Scheibner T . Absence of immunoreactive vasoactive intestinal polypeptide in tissue from the lungs of patients with asthma. N Engl J Med. 1989; 320(19):1244-8. DOI: 10.1056/NEJM198905113201904. View

19.

Lewis R, Austen K . The biologically active leukotrienes. Biosynthesis, metabolism, receptors, functions, and pharmacology. J Clin Invest. 1984; 73(4):889-97. PMC: 425099. DOI: 10.1172/JCI111312. View

20.

Iwata M, Tano M, Sugiyama S, Taki F, Satake T . Effect of azelastine, an antiasthmatic drug, on bronchial responsiveness in patients with bronchial asthma. Chest. 1989; 95(6):1231-4. DOI: 10.1378/chest.95.6.1231. View